Skip to main content
. 2017 Jul 10;8(38):63890–63900. doi: 10.18632/oncotarget.19173

Figure 4. The comparison of levels of metabolites in eicosanoid metabolism pathway.

Figure 4

*p < 0.05, hepatitis B virus cirrhosis (HBV-cirrhosis) vs healthy control; #p < 0.05, hepatocellular carcinoma (HCC) vs HBV-cirrhosis.